Implementing Pharmacogenetics with Kristen Reynolds
Kristen Reynolds takes a look at adverse drug reactions occurring secondary to identifiable genetic risk factors. She looks at the evidence supporting genetic testing, common mutations (CYP phenotypes), and how to decide whom to test.
Kristen Reynolds, Ph.D.
Kristen received her Ph.D. in Microbiology and Immunology from the University of Louisville. She currently serves as the Director of Laboratory Operations for the Pharmacogenetics Diagnostic Laboratory, LLC (PGXL Laboratories) in Louisville, KY, the first CLIA-certified laboratory to exclusively offer clinical pharmacogenetics testing in the United States. Dr. Reynolds is also a Clinical Instructor in the Department of Pathology and Laboratory Medicine, University of Louisville School of Medicine. View her LinkedIn Profile.